Personal

Primed UK

's fourth 𝗣𝗥𝗜𝗠𝗘𝗗𝘁𝗶𝗺𝗲* with Dr 

, CEO of Etheros Pharmaceuticals, a company developing small molecule enzyme mimetics for age-related and 

Jack is best known for his work to diagnose the causes of the progressive decline in R&D productivity in the 

 industry. He also has experience in drug and biotech investment at UBS and at Sanford Bernstein where he ran the European Healthcare teams.

What is it like to progress from a researcher to a CEO or enter the investment sector? 

Join us to hear Jack's journey, the future of the drug and 

 industry, ask your burning questions, and meet fellow members of the PRIMED community in relaxed, friendly setting ☺️

Whether you’re actively thinking about entrepreneurship or just curious about different career paths beyond the lab, we would love you to join us for this thoughtful and inspiring conversation! 🙂

PRIMEDTime April